VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Zevra Therapeutics, Inc. (ZVRA) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $609M · P/E 11.2 · revenue $136M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows